Vyripharm Enterprises, Inc. — Form D

Vyripharm Enterprises, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2021-10-28. The offering totals $300.0M, of which $300.0M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2021-10-28
• Form: D
• Accession: 0000895527-21-000037
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $300.0M
• Amount sold: $300.0M
• Investors: 2
• Date of first sale: 2021-10-13
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-418970

Issuer

• Name: Vyripharm Enterprises, Inc.
• CIK: 0001887609
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2020
• Address: 2450 HOLCOMBE BLVD, HOUSTON, TX, 77021
• Phone: (713) 357-1045

Officers, directors & promoters (2)

More

• CIK 1887609 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search